ANIP
ANI Pharmaceuticals Inc
Price:  
56.59 
USD
Volume:  
232,644.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ANIP WACC - Weighted Average Cost of Capital

The WACC of ANI Pharmaceuticals Inc (ANIP) is 7.2%.

The Cost of Equity of ANI Pharmaceuticals Inc (ANIP) is 7.60%.
The Cost of Debt of ANI Pharmaceuticals Inc (ANIP) is 6.95%.

Range Selected
Cost of equity 6.50% - 8.70% 7.60%
Tax rate 19.40% - 23.80% 21.60%
Cost of debt 6.90% - 7.00% 6.95%
WACC 6.3% - 8.0% 7.2%
WACC

ANIP WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.57 0.68
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.50% 8.70%
Tax rate 19.40% 23.80%
Debt/Equity ratio 0.24 0.24
Cost of debt 6.90% 7.00%
After-tax WACC 6.3% 8.0%
Selected WACC 7.2%